9 Feb 2018 14:00
9 February 2018
ImmuPharma PLC
("ImmuPharma" or the "Company")
Holding in Company
ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company, announces that on 8 February 2018 it received notification that Alto Invest no longer holds a notifiable interest in the Company.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
For further information, please contact:
ImmuPharma plc (www.immupharma.com) Tim McCarthy, Chairman Lisa Baderoon, Head of Investor Relations lisa.baderoon@immupharma.com | +44 (0) 207 152 4080
+44 (0) 7721 413 496
|
Northland Capital Partners Limited David Hignell, Jamie Sportswood (Corporate Finance) Rob Rees (Corporate Broking) |
+44 (0) 203 861 6625 |
Immupharma (IMM)